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I. INTRODUCTION 
The objective of this Report is to present to the Council and to the European Parliament 
statistics on the number of laboratory animals used in the EU, in accordance with Article 26 
of Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and 
administrative provisions of the Member States regarding the protection of animals used for 
experimental and other scientific purposes1. 
Three Reports have been published so far: 
– The first Report2, published in 1994, covered data on animals used in the year 1991; 
– The second Report3 was published 1999 and covered the data from 19964; 
– The third Report5 was published in 2003 and covered the data from 1999. 
The data in the first Report were quite mixed, since the Directive provides only little detail on 
the reporting requirements. However, a set of eight statistical standard reporting tables (EU 
Tables) was agreed between the Commission services and the competent authorities of the 
Member States during the compilation period of the second Report. A few Member States 
used these Tables already for their reporting to the second Report. 
For the third Report fourteen Member States submitted their data in accordance with the EU 
Tables, only one Member State used a different format because an amendment regarding data 
reporting was still needed in the existing federal law. 
For the present fourth Report, all fifteen Member States used the agreed EU Tables. Data 
were collected in 2002 with the exception of one Member State who collected data in 2001. 
This Report is accompanied by a “Commission Staff Working Paper - Report on the Statistics 
on the Number of Animals used for Experimental and other Scientific Purposes in the 
Member States of the European Union in the year 2002” (SEC (2004) XXX). The Staff 
Working Paper provides more details and also includes data from the single Member States 
and their respective comments. However, all conclusions at EU level are fully presented in 
this Report. 
                                                 
1 OJ L 358, 18.12.1986, p. 1. 
2 COM(1994) 195 final. 
3 COM(1999) 191 final. 
4 including 1997 data from France. 
5 COM(2003) 19 final. 
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II. DATA SUBMITTED AND GENERAL 
ASSESSMENT 
II.1. Data submitted by the Member States 
For the first time all Member States used the agreed EU Tables to submit their data. Data 
were collected in 2002, except for France who reported data from 2001. 
Member States in most cases applied a quality control check. This check greatly improved the 
coherence of the data amongst the different Tables. 
II.2. General assessment 
The main difference with the previous Reports is that the data now cover the complete range 
of procedures and their purposes. This allows, for the first time, for a more precise and 
comprehensive picture at EU level. 
Data are far more coherent amongst the different Tables than in previous Reports. 
Nevertheless, for the next Report coherence still needs to be improved. In this regard, the 
accession of the ten new Member States will require additional efforts. 
Data analysis in this Report could be extended to all eight EU Tables, thanks to the exclusive 
use of the EU Tables for data submission. 
Results in this Report were compared with previous Reports. However, comparisons were 
limited, because previous Reports were compiled on the basis of non-standard data. 
In addition, where comparisons are made in this Report, readers should note that one Member 
State (France) reported data from 1997 and 2001 (for the third and fourth Reports) whereas 
the other Member States reported from 1996 and 2002, respectively. Nevertheless, assuming 
that fluctuations in the annual numbers of animals used in a country are limited, it is safe to 
make semi-quantitative estimates of the observed trends. 
The total number of animals used for experimental and other scientific purposes in 2002 was 
10.7 million (with data from France from 2001). This indicates an increase beyond the 9.8 
million counted in 1999, but it is still a decrease compared to the 11.6 million of 1996. 
By far the biggest group of animals used was rodents and rabbits, as in the previous Reports. 
A significant increase in the use of fish has made the group of cold-blooded animals account 
for over 15 % of all animals used. 
Readers should note that the numbering of tables and figures in this Report is linked to the 
numbers of the EU Tables and not to the numbering of the chapters of the Report. 
Furthermore, the numbering of tables and figures in the Report is coherent with the 
numbering in the above-mentioned Commission Staff Working Paper. 
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III. RESULTS 
III.1. Results from EU Table 1: Species and number of animals used 
The total number of animals used in the EU Member States in 2002 (France reporting for 
2001) was 10.7 million. Mice (51 %) and rats (22 %) were by far the most used species (fig. 
1.1). Rodents and rabbits together represented more that ¾ of all animals used (78 %). Cold-
blooded animals (15 %) were used much more than compared to the previous report (6.6 %). 
The Artio and Perissodactyla group including horses, donkeys and cross-breds 
(Perrisodactyla), pigs, goats, sheep and cattle (Artiodactyla) represented only 1.2 %. 
Carnivores represented 0.3 % of the total number of animals used and primates represented 
0.1 %. 
Figure 1.1
Classes of animals
Mice 50,9%
Rats 21,5%
Other rodents  1,04% Rabbits 2,49%
Cold-blooded animals 
15,4%
Birds 4,99%
Artio+perissodactyla 
1,18%
Carnivores 0,28%
Prosimians+Monkeys
+Apes 0,10%
Guinea-Pigs 2,11%
Other mammals 
0,03%
 
Comparison with previous years 
In 2002 the total number of animals used increased by about 917,000 (9.3 %) with regard to 
1999 (table 1.3). The increase was mainly due to the additional use of about 970,000 fish 
(while other animal species decreased), raising the total of fish to almost 1.6 million. 
The proportion of rodents and rabbits used throughout 1996, 1999 and 2002 shows some 
fluctuation around 80 % (table 1.3). For cold-blooded animals the proportion used in 1996 
and 2002 is about 14 %, with a significant low in 1999 of 7 %. 
Furthermore, the number of rats and guinea-pigs decreased from 1999 to 2002 (data not 
shown here). There was only a relatively low increase in the use of mice but a more 
pronounced increase in the number of rabbits. The use of old world monkeys increased, too. 
However, in 2002 no great apes were used. - Although one Member State reported new and 
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old world monkeys together in 1999, one can nevertheless make the qualitative observation 
that in 2002 there was a decrease in the use of new world monkeys.  
An increase was similarly observed in the number of sheep, cattle and the number of other 
birds than quails used in 2002 in comparison to 1999. Goats on the other hand indicate a 
decrease. 
Table 1.3: Comparison between the numbers and proportions of classes of animals used 
in 1996, 1999 and 2002 
 1996 1999 2002 
Total number of animals 
used 
11,646,130 * 9,814,171 10,731,020 ** 
% Rodents-rabbits 81.3 86.9 78.04 
% Cold-blooded animals 12.9 6.6 15.4 
* 14 Member States reporting for 1996, one for 1997 
** 14 Member States reporting for 2002, one for 2001 
III.2. Further results from EU Table 1: Origin of animals used 
Although the origin only has to be reported for selected animal species, it is evident that the 
majority of the species in 2002 originated from the EU (fig. 1.2). However, for certain species 
(shown on the right side of the graph) there was a clear shift towards non-European origin. 
Note that in 2002 no apes were used. 
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Figure 1.2:   Origin of species
Other countries
ETS123 countries
EU countries
 
Comparison with 1999 
In comparison with 1999 there was an increase in the proportion of new world monkeys and 
quails of European origin. In contrast to this, there was a decrease of the proportion of 
hamsters and old world monkeys of European origin.  
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III.3. Results from EU Table 2: Purposes of the experiments 
In 2002 more than 60 % of animals were used in research and development for human 
medicine, veterinary medicine, dentistry and in fundamental biology studies (fig. 2.1). About 
16 % were used in production and quality control of products and devices in human medicine, 
veterinary medicine and dentistry, and about 10 % for toxicological and other safety 
evaluation. 
Figure 2.1
Purposes of experiments 
Research and develop 
human medicine 
+veteri+dentistry 28,4%
Production and quality 
control human 
medicine and dentistry 
13,6%
Education and training
 3,2%
Diagnosis of disease 
2,12%
Toxicological and other 
safety evaluation 9,93%
Production and quality 
control veterinary 
medicine 2,47%
Other 5,57%
Fundamental biology 
studies 34,7%
 
Comparison with previous years  
The percentage of animals used for research, development and quality control in the areas of 
human medicine, dentistry and veterinary medicine reached a high of 52 % in 1999, but was 
about 45 % in the other years (table 2.3). For fundamental biology studies the percentage 
increased from 25 % to 35 % since 1996. By comparison, the percentages of animals used for 
toxicological and safety evaluation remained very stable at about 10 %. 
Table 2.3: Comparison between the relative percentages of animal used for selected 
purposes in 1996, 1999 and 2002 
Purpose 1996 * 1999 ** 2002 
Research, development and quality 
control in human medicine, veterinary 
medicine and dentistry  
44% 52% 44.5% 
Fundamental biology studies  25% 30% 35% 
Toxicological and safety evaluation 9% 10% 9.9% 
* 13 Member States reported purposes of experiments 
** 14 Member Sates reported purposes of experiments 
With regard to selected species used for selected purposes, the global pattern (not illustrated 
here) has not changed much since 1999 (N.B.: Such data was not reported by Germany in 
1999), except for an increase of 27 % of the number of mice used in biological studies and for 
an average increase of about 14 % of the number of cold-blooded animals used for 
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fundamental biological studies, for research of products in human medicine, dentistry and 
veterinary science, for toxicological evaluation and also for education and training. 
Diagnosis of disease 
The diagnosis of diseases is important in the light of epidemics of farm animals such as mad 
cow disease, foot and mouth disease and swine fever. 
Since 1999 the percentage of rodents and rabbits used has increased from 79 % to 91 %, the 
use of cold-blooded animals decreased from 15 % to 1 %. The use of other animals did not 
change notably. 
III.4. Results from EU table 3: Toxicological or safety evaluation for type of 
products/endpoints 
Only 10 % of the total number of animals used for experimental purposes were used for 
toxicological and other safety evaluation. From these 10 %, 51 % were used for products or 
devices used for human medicine, veterinary medicine and dentistry (fig. 3.1), and only 2.1 % 
were used for the toxicological evaluation of animal feed, additives for human food 
consumption, cosmetics and household. 
The group of products/substances falling under the scrutiny of authorities concerned with the 
safety of health and the environment from chemical products, such as industrial chemicals and 
pesticides, used 24 % of the animals for toxicological and other safety evaluations. 
Comparison with 1999 
The proportion of animals used for toxicological and other safety evaluation of products to be 
used mainly in industry and agriculture has increased from 19 % to 24 %. Similarly, the 
proportion of animals used for the evaluation of potential or actual contaminants in the 
general environment has increased form 7 % to 12 %. 
III.5. Results from EU table 4: Animals used for studies of diseases 
In 2002 the number of animals used for studies of diseases of both humans and animals 
represented 58 % of the total number of animals used for experimental purposes (fig. 4.1). 
Comparison with the data of 1999 
In 2002 the pattern of study diseases was similar to that observed in 1999, except for an 
increase (from 10 to 15 %) of the proportion of animals used to study specific animal diseases 
and a marked decrease from (50 to 42 %) of the proportion of animals used for studying other 
human diseases. 
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Figure 3.1   Animals used in toxicological or other safety 
evaluations of products
3.4   Products/ 
substances used or 
intended to be used 
mainly in industry
12,75%
3.3     Products/ 
substances used or 
intended to be used 
mainly in agriculture
11,5%
3.9   Potential  or actual 
contaminants in the 
general environment 
which do not appear in 
other columns
12,4%
3.10    Other  
toxicological or safety 
evaluations
10,3%
3.8    Products/ 
substances used or 
intended to be used 
mainly as additives in 
food for animal 
consumption
0,3%
3.7    Products/ 
substances used or 
intended to be used 
mainly as additives in 
food for human 
consumption
1,2%
3.5   Products/ 
substances used or 
intended to be used 
mainly in the household
0,4%
3.6    Products/ 
substances used or 
intended to be used 
mainly as cosmetics or 
toiletries
0,25%
3.2    Products/ 
substances or devices 
for humanmedicine and 
dentistry and for 
veterinary medicine
50,7%
 
Figure 4.1
Proportion of animals used in studies of diseases
Other human 
diseases
41,9%
Human cancer 
(excl. evaluation of 
carcino hazards)
12,6%
Human nervous 
and mental 
disorder
23,8%
Human 
Cardiovascular 
diseases
7,3%
Specific animal 
diseases
14,5%
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The relative percentage of animals used for studies on diseases is shown in figure 4.2. Birds 
and cold-blooded animals were used to more than 80 % for studies on specific animal 
diseases. Some Member States indicated that both birds and fish were used for the purpose of 
vaccine testing, others could not confirm this. 
The pattern has not significantly changed since 1999 except for an increase in the percentage 
of use of cold-blooded animals for studies of animal diseases (from 56 to 80 %). 
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Figure 4.2
Species of animals used in studies of diseases
Specific animal
diseases  
Other human
diseases 
Human cancer
(excl. evaluation of
carcino hazards) 
Human nervous
and mental
disorder 
Human
Cardiovascular
diseases
 
III.6. Results from EU Table 5: Animals used in production and quality control of 
products for human medicine and dentistry and for veterinary medicine  
The number of animals used in production and quality control of products for human 
medicine and dentistry and for veterinary medicine represented 16 % of the total number of 
animals used for experimental purposes. Figure 5.1 gives the percentages of the animals used 
for different regulatory purposes in this area. 
The largest proportion (43 %) of animals in this area was used to simultaneously satisfy 
requirements from several legislations (national, Community, Council of Europe, and others). 
Some 21 % of the animals were not required for any regulatory purposes. To explain this 
relatively high proportion Member States reported a range of reasons, such as early stages in 
developmental processes or pilot studies, or additional tests to confirm earlier ambiguous test 
results. Member States also considered that some unclear data reporting may have been a 
reason. 
Remark: In 1999 the data provided by the Member States for EU Table 5 showed too much 
variability. Therefore, no interpretation of the data was possible, and consequently no 
comparison is possible now.  
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Figure 5.1:  Percentage of  animals used for regulatory requirements 
in the production and quality control of products and devices for 
human medicine and dentistry and for veterinary medicine
3.66
31.27
1.34
43.12
20.51
0.04
0.00 10.00 20.00 30.00 40.00 50.00
5.2     National legislation specific to a single EC Member
State
5.3     EC legislation including European Pharmacopoeia
(requirements)
5.4     Member Country of Council of Europe (but not EC)
legislation
5.5    Other legislation
5.6      Any combination of 5.2/ 5.3/ 5.4/ 5.5
 5.7       No regulatory requirements
 
III.7. Results from EU harmonized Table 6: Origin of regulatory requirements for 
animals used in toxicological and other safety evaluations 
The use of animals for regulatory requirements in the area of toxicology and other safety 
evaluations (fig. 6.1) follows a similar pattern to that of the use for regulatory purposes in 
human medicine, dentistry and in veterinary medicine (fig. 5.1). 
Comparison with 1999  
Animals used to simultaneously satisfy regulatory requirements from several legislations 
covered over half of the animal used in this area and have basically remained at the same level 
(about 55 %).  
The testing to satisfy national legislation specific to a single Member State related, for 
example, to national health and safety requirements at the work place. Testing for such 
purposes appears to have increased from 6 % to 11 %, but Member States considered that this 
effect might partly be due to the complexity of data collected from the reporting institutions. 
Contrary to the animals used in the areas of human medicine, dentistry and in veterinary 
medicine (fig. 5.1), the proportion of animals attributed to “no regulatory requirement” in the 
area of toxicology and other safety evaluations appears to have decreased from 15 % to 11 %. 
Member States reported a number of possible reasons for this effect, similar to the 
explanations for the area of human medicine and dentistry and for veterinary medicine (fig. 
5.1). 
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Figure 6.1:  Comparison of percentages of animals used for 
regulatory requirements for toxicological or other safety evaluation in 
1999 and 2002
2.36
0.34
3.58
6.37
16.40
6.14
53.67
15.05
10.51
19.34
55.52
10.71
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6.2     National
legislation specific to a
single EC Member
State
6.3     EC legislation
(including European
Pharmacopoeia
requirements)
6.4     Member Country
of Council of Europe
(but not EC) legislation
6.5    Other legislation
6.6      Any combination
of 6.2/ 6.3/ 6.4 /6.5
 6.7       No regulatory
requirements
1999
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III.8. Results of EU Table 7: Animals used in toxicity test for toxicological or other 
safety evaluations 
Figure 7.1 shows the percentage of animals used per toxicity test (group) in 1999 and 2002. 
Comparison with 1999  
As pointed out earlier, the number of animals used in toxicological and other safety 
evaluation represented 10 % of the total number of animals used for experimental purposes in 
the EU. 
The largest percentage of animals was due to acute and sub-acute toxicity tests, about 37 % in 
2002 and in 1999. With the addition of sub-chronic and chronic toxicity, the percentage of 
animals used in short and long term systemic toxicity testing accounted for 46 % and 52 %, 
respectively, in 2002 and 1999. About 20 % of the animals were used for tests on 
carcinogenicity, mutagenicity and toxicity to reproduction in both years. 
In comparison with the data of 1999, there is a certain decrease in the percentage of animals 
used for sub-chronic and chronic toxicity tests from about 14 % to 9 % and for reproductive 
and developmental toxicity from about 15 % to 12 %, and an increase in the percentage of 
animals used in detecting toxicity to aquatic vertebrates from 0.5 % to 4.5 %.  
An increase is also observed, from about 20 % to 24 %, in the percentage of animals used for 
“other” toxicity tests than those listed in the statistical Table. 24 % is about ¼ of all such 
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animals and thus a considerable proportion. Member States considered that this may be due to 
a variety of tests conducted by universities or institutions, which may not follow specific 
guidelines and were therefore summed up by researchers under “other”. Member States also 
indicated that “other” might include tests linked to haemotoxicology, toxicokinetics, 
pyrogenicity, biocompatibility, immunotoxicology, enzyme induction and allergic reactions 
of animals. 
Figure 7.1
Comparison of the percentages of animals used in toxicity tests 
for toxicological or other safety evaluation in 1999 and 2002
19,54
0,54
15,42
6,10
13,75
6,08
38,28
24,11
4,53
12,10
7,31
9,38
5,85
36,72
0,00 10,00 20,00 30,00 40,00 50,00
Acute and sub-acute
toxicity (including limit
tests)
irritation/sensitization 
Sub- chronic and chronic
toxicity
Mutagenicity and
carcinogenicity
 Reproductive and develop.
toxicity
Toxicity to aquatic
vertebrates not included in
other columns
  Other
1999
2002
 
III.9. Results of EU Table 8: Type of toxicity tests carried out for toxicological or 
other safety evaluations of products 
As pointed out earlier, animals used in toxicological and other safety evaluation represent 10 
% of the total number of animals used for experimental purposes in the EU. 
A substantial number of toxicity tests were performed for products or devices for human 
medicine, dentistry and veterinary medicine. Other notable groups of products requiring 
toxicological testing were products used mainly in agriculture and products intended mainly 
for industry. 
Remark: In 1999 the data provided by the Member States for EU Table 8 showed too much 
variability. Therefore, no interpretation of the data was possible, and consequently no 
comparison is possible now. 
